These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8859000)

  • 1. Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors.
    Bergman MR; Holycross BJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):247-54. PubMed ID: 8859000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
    Cottam HB; Shih H; Tehrani LR; Wasson DB; Carson DA
    J Med Chem; 1996 Jan; 39(1):2-9. PubMed ID: 8568809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
    Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
    Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.
    Endres S; Fülle HJ; Sinha B; Stoll D; Dinarello CA; Gerzer R; Weber PC
    Immunology; 1991 Jan; 72(1):56-60. PubMed ID: 1847694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.
    Badger AM; Olivera DL; Esser KM
    Circ Shock; 1994 Dec; 44(4):188-95. PubMed ID: 7628060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoproterenol inhibits bacterial lipopolysaccharide-stimulated release of tumor necrosis factor-alpha from human heart tissue.
    Smart KR; Warejcka DJ; Castresana MR; Dalton ML; Webb JG; Newman WH
    Am Surg; 2000 Oct; 66(10):947-51. PubMed ID: 11261622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
    Semmler J; Gebert U; Eisenhut T; Moeller J; Schönharting MM; Alléra A; Endres S
    Immunology; 1993 Apr; 78(4):520-5. PubMed ID: 8388363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response.
    Comstock KL; Krown KA; Page MT; Martin D; Ho P; Pedraza M; Castro EN; Nakajima N; Glembotski CC; Quintana PJ; Sabbadini RA
    J Mol Cell Cardiol; 1998 Dec; 30(12):2761-75. PubMed ID: 9990546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures.
    Leithäuser ML; Rob PM; Sack K
    Exp Nephrol; 1997; 5(1):100-4. PubMed ID: 9052855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tumor necrosis factor-alpha production in the isolated rat heart stimulated by bacterial lipopolysaccharide or reactive oxygen.
    Jennings GR; Castresana MR; Newman WH
    Am Surg; 2004 Sep; 70(9):797-800. PubMed ID: 15481297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines.
    Leist M; Auer-Barth S; Wendel A
    J Pharmacol Exp Ther; 1996 Mar; 276(3):968-76. PubMed ID: 8786577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
    Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N
    BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.
    Meldrum DR; Dinarello CA; Shames BD; Cleveland JC; Cain BS; Banerjee A; Meng X; Harken AH
    Circulation; 1998 Nov; 98(19 Suppl):II214-8; discussion II218-9. PubMed ID: 9852905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.